ORLANDO — In this exclusive video from Advances in IBD 2018, Raymond Cross, MD, MS, director of the inflammatory bowel disease program at the University of Maryland School of Medicine talks about a case discussion panel he helped lead on mimics of IBD.
“We tend to think of these things in patients that tend to migrate from the United States that are at risk for infectious diseases,” Cross told Healio Gastroenterology and Liver Disease. “Patients that are older at onset where we worry about things like non-steroidal-induced injury, chronic ischemic injury, malignancy and so forth.”
The panel dug into four case studies that involved mimics of IBD, including a patient with intestinal tuberculosis, a patient with ipilimumab-induced colitis and a patient with segmental colitis associated with diverticular disease.
“This is something that we typically see in older adults that, fortunately, is often managed best with some of the entry-level medicines for ulcerative colitis, such as mesalamine,” Cross said.
Disclosures: Cross reports no relevant financial disclosures.